Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy for recurrent or advanced uterine cancer (uterine sarcoma). The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Sarcoma

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Sarcoma | Phase 2 | Status: TERMINATED